Incidence and Risk Factors of Subjective Memory Complaints in Women in Central Bogor City, Indonesia

Pradono, Julianty; Sudikno, Sudikno; Suswanti, Ika; Turana, Yuda

doi:10.33879/amh.113.2019.08020

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is evidence that high blood sugar may be a risk factor for dementia, even amongst people without diabetes [45]. A recent prospective cohort study reported that suffering from migraine increases the risk of developing Subjective Memory Complaints more than older age and coronary heart disease [171]. It has been proposed that migraine, mainly migraine with aura, is a risk factor for cardiovascular disease in general, as well as for stroke [115].…”

Section: Kilic Et Al's Data On Inhibited Glycogen Phosphorylation In ...mentioning

confidence: 99%

Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review

Moro¹,

Rota

Pirovano³

et al. 2022

The Journal of Pain

View full text Add to dashboard Cite

Section: Kilic Et Al's Data On Inhibited Glycogen Phosphorylation In ...mentioning

confidence: 99%

Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review

Moro¹,

Rota

Pirovano³

et al. 2022

The Journal of Pain

View full text Add to dashboard Cite

Hormone Replacement Therapy and Alzheimer’s Disease: Current State of Knowledge and Implications for Clinical Use

Sayfullaeva,

McLoughlin,

Kwakowsky

2024

JAD

View full text Add to dashboard Cite

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder responsible for over half of dementia cases, with two-thirds being women. Growing evidence from preclinical and clinical studies underscores the significance of sex-specific biological mechanisms in shaping AD risk. While older age is the greatest risk factor for AD, other distinct biological mechanisms increase the risk and progression of AD in women including sex hormones, brain structural differences, genetic background, immunomodulation and vascular disorders. Research indicates a correlation between declining estrogen levels during menopause and an increased risk of developing AD, highlighting a possible link with AD pathogenesis. The neuroprotective effects of estrogen vary with the age of treatment initiation, menopause stage, and type. This review assesses clinical and observational studies conducted in women, examining the influence of estrogen on cognitive function or addressing the ongoing question regarding the potential use of hormone replacement therapy (HRT) as a preventive or therapeutic option for AD. This review covers recent literature and discusses the working hypothesis, current use, controversies and challenges regarding HRT in preventing and treating age-related cognitive decline and AD. The available evidence indicates that estrogen plays a significant role in influencing dementia risk, with studies demonstrating both beneficial and detrimental effects of HRT. Recommendations regarding HRT usage should carefully consider the age when the hormonal supplementation is initiated, baseline characteristics such as genotype and cardiovascular health, and treatment duration until this approach can be more thoroughly investigated or progress in the development of alternative treatments can be made.

show abstract

Hormonal contraception and risk for cognitive impairment or Alzheimer's disease and related dementias in young women: a scoping review of the evidence

Gregory,

Booi,

Jenkins

et al. 2023

Front. Glob. Womens Health

View full text Add to dashboard Cite

IntroductionWomen are significantly more likely to develop Alzheimer's disease and related dementias (ADRD) than men. Suggestions to explain the sex differences in dementia incidence have included the influence of sex hormones with little attention paid to date as to the effect of hormonal contraception on brain health. The aim of this scoping review is to evaluate the current evidence base for associations between hormonal contraceptive use by women and non-binary people in early adulthood and brain health outcomes.MethodsA literature search was conducted using EMBASE, Medline and Google Scholar, using the keywords “hormonal contraception” OR “contraception” OR “contraceptive” AND “Alzheimer*” OR “Brain Health” OR “Dementia”.ResultsEleven papers were identified for inclusion in the narrative synthesis. Studies recruited participants from the UK, USA, China, South Korea and Indonesia. Studies included data from women who were post-menopausal with retrospective data collection, with only one study contemporaneously collecting data from participants during the period of hormonal contraceptive use. Studies reported associations between hormonal contraceptive use and a lower risk of ADRD, particularly Alzheimer's disease (AD), better cognition and larger grey matter volume. Some studies reported stronger associations with longer duration of hormonal contraceptive use, however, results were inconsistent. Four studies reported no significant associations between hormonal contraceptive use and measures of brain health, including brain age on MRI scans and risk of AD diagnosis.DiscussionFurther research is needed on young adults taking hormonal contraceptives, on different types of hormonal contraceptives (other than oral) and to explore intersections between sex, gender, race and ethnicity.Systematic Review Registrationhttps://doi.org/10.17605/OSF.IO/MVX63, identifier: OSF.io: 10.17605/OSF.IO/MVX63

show abstract

Incidence and Risk Factors of Subjective Memory Complaints in Women in Central Bogor City, Indonesia

Cited by 3 publications

References 0 publications

Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review

Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review

Hormone Replacement Therapy and Alzheimer’s Disease: Current State of Knowledge and Implications for Clinical Use

Hormonal contraception and risk for cognitive impairment or Alzheimer's disease and related dementias in young women: a scoping review of the evidence

Contact Info

Product

Resources

About